InfuSystem Holdings (INFU) Cash & Equivalents (2010 - 2026)

InfuSystem Holdings has reported Cash & Equivalents for 17 years, with the latest figure at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 39.84% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 39.84% YoY), and the FY2025 full-year result was $3.2 million, up 504.55% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $2.1 million, down from $3.2 million in the prior quarter.
• The five-year high for Cash & Equivalents was $3.2 million in Q4 2025, with the low at $134000.0 in Q2 2023.
• Historically, Cash & Equivalents has averaged $727882.4 across 5 years, with a median of $380000.0 in 2024.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 85.33% — and 2025, when it surged 504.55%.
• InfuSystem Holdings' Cash & Equivalents stood at $165000.0 in 2022, then jumped by 40.0% to $231000.0 in 2023, then soared by 128.14% to $527000.0 in 2024, then surged by 504.55% to $3.2 million in 2025, then sank by 33.9% to $2.1 million in 2026.
• The last three Cash & Equivalents figures came in at $2.1 million (Q1 2026), $3.2 million (Q4 2025), and $955000.0 (Q3 2025), per Business Quant data.